On June 27, 2023, the Food and Drug Administration (FDA) issued its final guidance for the presentation of “Quantitative Efficacy and Risk Information” in direct-to-consumer (DTC).
FDA Releases Final Guidance on Promotional Labeling natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
The wait is finally over. On June 7, 2023, after remaining silent for over an entire year, the US Food and Drug Administration ("FDA") Office of Prescription Drug Promotion ("OPDP") issued its first untitled.
The wait is finally over. On June 7, 2023, after remaining silent for over an entire year, the US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”).
US FDA OPDP issued first untitled letter of 2023 to Xeris Pharmaceuticals concerning promotional material for Recorlev tablets, citing misleading claims on company webpages.